Stifel Nicolaus Has Lowered Expectations for Kits Eyecare (TSE:KITS) Stock Price

Key Points

• Stifel Nicolaus cut its price objective on Kits Eyecare to C$21.00 (from C$24.00) while maintaining a "buy" rating, with the new target implying roughly an 83.7% upside from the prior close.
• Other brokers also trimmed targets (ATB Cormark to C$16.75; Desjardins to C$23.00); the stock carries an average analyst rating of Buy and a consensus target of C$20.69.
• KITS shares fell about 7.7% to C$11.43 on elevated volume (306,356 vs. average 115,911); the 12‑month range is C$11.12–C$22.56, with a market cap of C$388.5M and a P/E of 127.

Kits Eyecare (TSE:KITS - Get Free Report) had its price objective dropped by equities research analysts at Stifel Nicolaus from C$24.00 to C$21.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage presently has a "buy" rating on the stock. Stifel Nicolaus' price objective suggests a potential upside of 83.73% from the stock's previous close.

Other analysts have also recently issued reports about the company. ATB Cormark Capital Markets lowered their target price on Kits Eyecare from C$20.00 to C$16.75 and set a "speculative buy" rating for the company in a research note on Thursday. Desjardins cut their price target on shares of Kits Eyecare from C$25.00 to C$23.00 and set a "buy" rating on the stock in a research note on Thursday. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of C$20.69.

Kits Eyecare Trading Down 7.7%

KITS stock traded down C$0.95 during midday trading on Thursday, hitting C$11.43. 306,356 shares of the company's stock were exchanged, compared to its average volume of 115,911. Kits Eyecare has a one year low of C$11.12 and a one year high of C$22.56. The firm has a market cap of C$388.51 million, a PE ratio of 127.00 and a beta of 0.46.

Kits Eyecare (TSE:KITS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The business had revenue of C$57.47 million during the quarter.

About Kits Eyecare

KITS TSX: KITS is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.